ALA DAHHAN

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology ROCHESTER, NY NPI 1013099787

General Payments — all program years on this page

$2,614.75

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 47
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $86.60 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Education $58.5219
Food and Beverage $28.081

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Retrophin, Inc. $58.5219
Aurinia Pharma U.S., Inc. $28.081

By program year

Program yearAmountRecords
2018 $1,995.3820
2019 $269.333
2020 $99.001
2022 $14.811
2023 $149.632
2024 $86.6020

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1149899144 Travere Therapeutics, Inc. $3.08 01/03/2024 Education Undisputed 01/23/2026 View at CMS
1149899148 Travere Therapeutics, Inc. $3.08 01/23/2024 Education Undisputed 01/23/2026 View at CMS
1149899152 Travere Therapeutics, Inc. $3.08 02/12/2024 Education Undisputed 01/23/2026 View at CMS
1149899156 Travere Therapeutics, Inc. $3.08 02/21/2024 Education Undisputed 01/23/2026 View at CMS
1149899160 Travere Therapeutics, Inc. $3.08 03/05/2024 Education Undisputed 01/23/2026 View at CMS
1149899164 Travere Therapeutics, Inc. $3.08 03/14/2024 Education Undisputed 01/23/2026 View at CMS
1149899168 Travere Therapeutics, Inc. $3.08 06/20/2024 Education Undisputed 01/23/2026 View at CMS
1149899172 Travere Therapeutics, Inc. $3.08 08/06/2024 Education Undisputed 01/23/2026 View at CMS
1149899176 Travere Therapeutics, Inc. $3.08 08/19/2024 Education Undisputed 01/23/2026 View at CMS
1149899180 Travere Therapeutics, Inc. $3.08 08/26/2024 Education Undisputed 01/23/2026 View at CMS
1149899184 Travere Therapeutics, Inc. $3.08 09/16/2024 Education Undisputed 01/23/2026 View at CMS
1149899188 Travere Therapeutics, Inc. $3.08 09/24/2024 Education Undisputed 01/23/2026 View at CMS
1149899192 Travere Therapeutics, Inc. $3.08 10/01/2024 Education Undisputed 01/23/2026 View at CMS
1149899195 Travere Therapeutics, Inc. $3.08 04/08/2024 Education Undisputed 01/23/2026 View at CMS
1149899199 Travere Therapeutics, Inc. $3.08 04/23/2024 Education Undisputed 01/23/2026 View at CMS
1149899203 Travere Therapeutics, Inc. $3.08 05/06/2024 Education Undisputed 01/23/2026 View at CMS
1149919447 Travere Therapeutics, Inc. $3.08 05/14/2024 Education Undisputed 01/23/2026 View at CMS
1149919451 Travere Therapeutics, Inc. $3.08 06/04/2024 Education Undisputed 01/23/2026 View at CMS
1149919455 Travere Therapeutics, Inc. $3.08 06/12/2024 Education Undisputed 01/23/2026 View at CMS
1150678765 Aurinia Pharma U.S., Inc. $28.08 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.